Genetic interactions among AGT, ACE, and Angiotensin II Type 1 Receptor (AT1R), which are part of the same metabolic pathway, can influence the synthesis of their respective end-products and collectively elevate the risk of T2D and other disorders. This evidence concerns the gene AGTR1 and type 2 diabetes mellitus.